The Union Ministry of Well being has notified amendments to the Medicines Guidelines, 1945 to increase the scope of Schedule H2 and introduce extra classes of medicines beneath the QR code-based observe and hint framework.
Underneath the amended provisions, all vaccines, antibacterial medicine, narcotics and psychotropic medicine and all anti-cancer medicine coated by the Narcotic Medication and Psychotropic Substances Act, 1985 (NDPS) are included in Schedule H2 of the Medication Guidelines, 1945.
The amendments would require producers of those drug merchandise to print or affix a barcode or fast response (QR) code on the product’s main packaging label or, if area is inadequate, on the secondary packaging label. QR codes retailer info that may be accessed via software program functions to facilitate product authentication and verification all through the provision chain.
The QR code incorporates key product info such because the distinctive product identification code, generic and model title, producer’s title and tackle, batch quantity, manufacturing date and expiry date, manufacturing license quantity, and excipient particulars if relevant.
The QR code-based identification requirement was beforehand relevant to the highest 300 drug manufacturers within the nation. The proposed amendments considerably increase protection to incorporate all vaccines, antibiotics, anti-cancer medicine, narcotics and psychotropic medicine, thereby increasing the scope of traceability and strengthening safeguards towards the distribution of counterfeit and substandard medicines.
In line with a launch issued by the ministry, the improved traceability mechanism will facilitate the authentication of medicines at varied levels of the provision chain, permitting for improved monitoring and verification of medicines.
The measure is predicted to strengthen regulatory oversight and help efforts to curb the circulation of faux medicines available in the market. It should additionally contribute to the nationwide struggle towards antimicrobial resistance (AMR) by strengthening the identification and monitoring of counterfeit and substandard antimicrobial merchandise.
Recognizing the necessity to present trade and different stakeholders with ample time for implementation, the Division has established a phased timeline for compliance. Rules on vaccines, narcotics and psychotropic medicine, and anticancer medicine will come into impact from July 1, 2027, and laws on antimicrobials will come into impact from July 1, 2028.
In the meantime, the ministry additionally notified amendments to the Medical Institutions (Registration and Regulation) Act, 2010 on June 22, 2026 beneath the Jan Vishwas (Modification of Provisions) Act, 2026, which was revealed within the Official Gazette on April 8, 2026.
The reforms purpose to advertise trust-based governance, cut back compliance burdens, enhance ease of doing enterprise, and guarantee correct regulatory enforcement, whereas persevering with to guard affected person security and high quality of well being care providers throughout the nation.
The proposed amendments additionally present for a structured adjudication course of, together with a chance for a listening to earlier than fines are imposed, a mechanism for positive restoration, and an appeals framework for aggrieved events.
“These measures are anticipated to advertise voluntary compliance, cut back pointless litigation, and guarantee proportionate motion in circumstances of minor procedural non-compliance, whereas sustaining regulatory oversight of medical services,” the discharge states.
“By changing prison penalties for procedural errors with honest and balanced governance mechanisms, this reform goals to enhance the benefit of doing enterprise within the healthcare sector, whereas sustaining the very best requirements of affected person care, security and accountability,” it added.
issued – June 25, 2026 6:47 PM IST
